Auric Pharma, Neuro-Biotech Corp. deal

Auric will complete its previously announced acquisition of Neuro-Biotech on April 5. Both parties accepted the terms of the deal and completed due diligence. Neuro-Biotech's president and CEO, Boris Oleknovich, will become president of the newco, which will be headquartered in Kazan, Russia. Norman Hathaway, Auric's president and CEO, will become CEO. ...